Related Experiment Video
Updated: Jul 18, 2026

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
Does antibiotic selection impact patient outcome?
Stephan Harbarth1, Vandack Nobre, Didier Pittet
1Infection Control Program and Division of Infectious Diseases, University of Geneva Hospitals, Geneva, CH-1211, Switzerland. stephan.harbarth@hcuge.ch
Abstract:
Inadequate antibiotic therapy, generally defined as microbiologically ineffective anti-infective therapy against the causative pathogen, can influence patient outcome. However, the detrimental effects of inadequate antibiotic therapy seem to become weaker in the most severely ill patients with short life expectancies. In addition to severity of illness, other methodological issues should be carefully examined in studies assessing the excess mortality due to inadequate therapy. To adjust for confounding as much as possible in order to obtain an unbiased estimate of the magnitude of the effect of inadequate therapy is a key methodological challenge for future research. With regard to the choice of antibiotic agents, beta-lactam and aminoglycoside combination therapy does not seem to improve clinical outcome in most cases of sepsis caused by gram-negative bacteria, including Pseudomonas aeruginosa bacteremia. A potential benefit of combination therapy in the treatment of severe pneumococcal sepsis has been suggested in several observational studies, but recently published data have disputed this hypothesis. Finally, better risk scores and laboratory tools are urgently needed to improve the adequacy of empirical antibiotic therapy and patient outcomes.
Insights
Inadequate antibiotic therapy may impact patient outcomes, but its effect lessens in critically ill patients. Future research must address methodological challenges to accurately estimate the impact of antibiotic therapy on mortality.
Area of Science:
- Infectious Diseases
- Clinical Pharmacology
- Critical Care Medicine
Background:
- Inadequate antibiotic therapy, defined as ineffective treatment against the pathogen, can affect patient outcomes.
- The impact of inadequate therapy may be less pronounced in severely ill patients with limited life expectancy.
- Methodological challenges exist in studies assessing mortality due to inadequate antibiotic therapy.
Purpose of the Study:
- To examine the influence of inadequate antibiotic therapy on patient outcomes.
- To highlight methodological challenges in research on inadequate antibiotic therapy.
- To review current evidence on antibiotic combination therapy for sepsis.
Main Methods:
- Review of existing literature on antibiotic therapy and patient outcomes.
- Analysis of studies assessing mortality associated with inadequate antibiotic therapy.
- Examination of clinical trial data on combination antibiotic therapy for sepsis.
Main Results:
- The detrimental effects of inadequate antibiotic therapy appear diminished in critically ill patients.
- Beta-lactam and aminoglycoside combination therapy generally does not improve outcomes for gram-negative sepsis.
- Evidence supporting combination therapy for severe pneumococcal sepsis is conflicting.
Conclusions:
- Accurate estimation of inadequate antibiotic therapy's effect requires addressing confounding factors.
- Current evidence does not strongly support routine combination antibiotic therapy for gram-negative or pneumococcal sepsis.
- Improved risk scores and laboratory tools are needed to optimize empirical antibiotic therapy and patient outcomes.
Related Concept Videos
Antibiotic Selection
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Microbiota Modulation by Antibiotics
Development of Antibiotic Resistance
Urine Studies II: Urine Culture and Sensitivity Test
